These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34800688)

  • 41. Impact of Public Health Interventions on Seasonal Influenza Activity During the COVID-19 Outbreak in Korea.
    Lee H; Lee H; Song KH; Kim ES; Park JS; Jung J; Ahn S; Jeong EK; Park H; Kim HB
    Clin Infect Dis; 2021 Jul; 73(1):e132-e140. PubMed ID: 32472687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis.
    Post LA; Lin JS; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh LN; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e25454. PubMed ID: 33464207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling study.
    Rosello A; Barnard RC; Smith DRM; Evans S; Grimm F; Davies NG; ; Deeny SR; Knight GM; Edmunds WJ
    BMC Infect Dis; 2022 Apr; 22(1):324. PubMed ID: 35365070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolution of disease transmission during the COVID-19 pandemic: patterns and determinants.
    Zhu J; Gallego B
    Sci Rep; 2021 May; 11(1):11029. PubMed ID: 34040044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Public health practitioner perspectives on dealing with measles outbreaks if high anti-vaccination sentiment is present.
    Robinson P; Wiley K; Degeling C
    BMC Public Health; 2021 Apr; 21(1):578. PubMed ID: 33832447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Public health interventions successfully mitigated multiple incursions of SARS-CoV-2 Delta variant in the Australian Capital Territory.
    Hall RN; Jones A; Crean E; Marriott V; Pingault N; Marmor A; Sloan-Gardner T; Kennedy K; Coleman K; Johnston V; Schwessinger B
    Epidemiol Infect; 2023 Feb; 151():e30. PubMed ID: 36786292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19 Outbreaks in Nursing Homes Despite Full Vaccination with BNT162b2 of a Majority of Residents.
    Lafuente-Lafuente C; Rainone A; Guérin O; Drunat O; Jeandel C; Hanon O; Belmin J;
    Gerontology; 2022; 68(12):1384-1392. PubMed ID: 35313315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccine breakthrough infections in a highly-vaccinated Australian population during a SARS-CoV-2 Delta outbreak.
    Sheel M; Vun Voo T; Pingault N; Sloan-Gardner TS; Marmor A; Kirk MD; Johnston V; Coleman K
    Commun Dis Intell (2018); 2022 Jun; 46():. PubMed ID: 35739073
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 variants-associated outbreaks of COVID-19 in a tertiary institution, North-Central Nigeria: Implications for epidemic control.
    Adeyemi OO; Ndodo ND; Sulaiman MK; Ayansola OT; Buhari OIN; Akanbi OA; Bolarinwa OA; Chukwu C; Joel IY; Omoare AA; Wahab KW; Obiekea C; Buhari MO; Ahumibe A; Kolawole CF; Okoi C; Omotesho OB; Mba N; Adeniyi O; Babatunde O; Akintunde N; Ayinla G; Akande OW; Odunola RA; Saka MJ; Musa OI; Durotoye IA; Ihekweazu C; Adetifa IM; Fadeyi A
    PLoS One; 2023; 18(1):e0280756. PubMed ID: 36696405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating local outbreak risks and the effects of non-pharmaceutical interventions in age-structured populations: SARS-CoV-2 as a case study.
    Lovell-Read FA; Shen S; Thompson RN
    J Theor Biol; 2022 Feb; 535():110983. PubMed ID: 34915042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The resurgence risk of COVID-19 in China in the presence of immunity waning and ADE: A mathematical modelling study.
    Zhou W; Tang B; Bai Y; Shao Y; Xiao Y; Tang S
    Vaccine; 2022 Nov; 40(49):7141-7150. PubMed ID: 36328883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
    Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigating the association between COVID-19 vaccination and care home outbreak frequency and duration.
    Bradley DT; Murphy S; McWilliams P; Arnold S; Lavery S; Murphy J; de Lusignan S; Hobbs R; Tsang RSM; Akbari A; Torabi F; Beggs J; Chuter A; Shi T; Vasileiou E; Robertson C; Sheikh A; Reid H; O'Reilly D
    Public Health; 2022 Feb; 203():110-115. PubMed ID: 35038629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimal timing and effectiveness of COVID-19 outbreak responses in China: a modelling study.
    Zhang AZ; Enns EA
    BMC Public Health; 2022 Apr; 22(1):679. PubMed ID: 35392861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of non-pharmaceutical interventions and vaccination on COVID-19 outbreaks in Nunavut, Canada: a Canadian Immunization Research Network (CIRN) study.
    Vilches TN; Abdollahi E; Cipriano LE; Haworth-Brockman M; Keynan Y; Sheffield H; Langley JM; Moghadas SM
    BMC Public Health; 2022 May; 22(1):1042. PubMed ID: 35614429
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.
    Hellewell J; Abbott S; Gimma A; Bosse NI; Jarvis CI; Russell TW; Munday JD; Kucharski AJ; Edmunds WJ; ; Funk S; Eggo RM
    Lancet Glob Health; 2020 Apr; 8(4):e488-e496. PubMed ID: 32119825
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A SARS-CoV-2 Omicron outbreak among crew members on a cruise ship in Germany in early 2022.
    Bühler S; Busch P; Wittkamp P; Alpers K; Doerre A; Plenge-Bönig A; Fornaçon J; Schäfers C; Reichstein A; Grassl B; Hewelt E; Dirksen-Fischer M; Kleine-Kampmann S
    Int Marit Health; 2023; 74(4):235-242. PubMed ID: 38111243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determining the level of social distancing necessary to avoid future COVID-19 epidemic waves: a modelling study for North East London.
    Cheetham N; Waites W; Ebyarimpa I; Leber W; Brennan K; Panovska-Griffiths J
    Sci Rep; 2021 Mar; 11(1):5806. PubMed ID: 33707546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward.
    Wi YM; Kim SH; Peck KR
    J Korean Med Sci; 2022 Jan; 37(4):e28. PubMed ID: 35075827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.